"10.1371_journal.pone.0017163","plos one","2011-02-11T00:00:00Z","Lorenza Mittempergher; Jorma J de Ronde; Marja Nieuwland; Ron M Kerkhoven; Iris Simon; Emiel J Th. Rutgers; Lodewyk F A Wessels; Laura J Van't Veer","Divisions of Experimental Therapy, Molecular Biology, Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Central Microarray Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Agendia BV, Amsterdam, The Netherlands","Conceived and designed the experiments: LM LJVV EJTR. Performed the experiments: LM MN RMK. Analyzed the data: LM JJR LJVV LFAW. Contributed reagents/materials/analysis tools: IS RMK. Wrote the paper: LM JJR LJVV LFAW.","LJVV is a named inventor on a patent for the 70-gene signature used in this study and is a shareholder in Agendia BV, the commercial entity that markets the 70-gene signature as MammaPrintÂ®. IS is employed by Agendia BV. However, what is stated above does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","Lorenza Mittempergher","LM",8,TRUE,3,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
